FLNA
Filana Therapeutics, Inc.Company with tickers: FLNA
CIK
1069530
CUSIP
14817C107
Shares Outstanding
48,307,896
13F Activity (30d)
7 filings
6 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Claude Nicaise, M.D. | Director | Appointed | 2026-06-15 |
| Pierre Gravier | Director | Appointed | 2026-06-15 |
| Richard J. Barry | Director | Appointed | 2026-06-15 |